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Abstract
Eye surgery is always progresses as the same way that the science advances. New
emerging technologies such as bio-printing in 3D, developments and mathematical
modeling in prototyping lab- on- a chip, visual implants, new biopolymers started to
use in eye enucleation, detection of eye biomarkers at the cellular level, bio-sensors
and new diagnostic tests should be considered to improve the quality of life of pa‐
tients after surgery. This chapter provides a review of new and emerging technologies
which are already working on global research centers. Emerging and converging tech‐
nologies are terms used interchangeably to indicate the emergence and convergence
of new technologies with demonstrated potential as disruptive technologies. Among
them are: nanotechnology, biotechnology, information technology and communica‐
tion, cognitive science, robotics, and artificial intelligence that have been launched as
innovative products that promise to improve the quality of life and vision of patients
with ocular compromised or low vision impairment. Some acronyms for these are:
NBIC: Nanotechnology, Biotechnology, Information technology and Cognitive sci‐
ence. GNR: Genetics, Nanotechnology and Robotics. GRIN: Genetic, Robotic, Informa‐
tion, and Nanotechnology. BANG: Bits, Atoms, Neurons and Genes. Otherwise, to
training ophthalmologist on news techniques, sophisticated simulation machines has
been developing around the world.
Keywords: Artificial retina, nanotechnology, visual health, ocular prosthesis, retina
1. Introduction
Eye surgery always progresses the same way as science advances. New emerging technologies
such as bio-printing in 3D, mathematical modeling, and developments in prototyping lab-on-
a-chip, visual implants, and new biopolymers have started to be used in eye enucleation, the
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detection of eye biomarkers at the cellular level, bio-sensors, and new diagnostic tests that are
considered to improve the quality of life of patients after surgery.
This chapter provides a review of new and emerging technologies, which are already working
in global research centers. The term “emerging technologies” refers to the implementation of
new innovative products designed to improve the quality of life. Some acronyms used are:
NBIC: Nanotechnology, Biotechnology, Information technology, and Cognitive science.
GNR: Genetics, Nanotechnology, and Robotics.
GRIN: Genetic, Robotic, Information, and Nanotechnology.
BANG: Bits, Atoms, Neurons, and Genes.
New technologies, such as nanotechnology, artificial intelligence, and genetics among others,
have emerged not only to create alternatives to health service, but also to provide alternatives
for new ophthalmologists in their surgical practice. There are increasing reviews in literature
about the relationship with developments such as new surgical techniques not only for
refractive surgery but also for simulation prior to cataract. Retina implants incorporating
electronic devices, stem cells, and new inserts for corneal implants are some of the many
devices made from biopolymers and electronics that have the promise to be an alternative for
visually impaired patients.
Otherwise, as a response to training ophthalmologists on these new techniques, sophisticated
simulation devices have been developed around the world [1].
2. Problem statement
Eye surgery has always been characterized by innovation, the introduction of new surgical
techniques, and also the inclusion of technology. But being so specialized, this information is
not readily disclosed to the targeted patients who directly require these new developments in
order to restore their vision or improve the quality of their life. Otherwise, medical students
and residents in ophthalmology require an overview of these new developments to plan the
training for these new techniques and apply it to patients that have these requirements
according to the new protocols, inclusion criteria, and the available technology in the operating
room in order to plan new investments for clinical practice and training. Knowing where you
are in making this progress, communication and the creation of partnerships between experts
are priorities to be able to respond to the patients’ needs.
This chapter intends to update eye surgeons in new biopolymers and innovations for ocular
prostheses and visual implants for visual care. In the previous years, there are a lot of inno‐
vations such us visual implants, artificial silicon retinas, suprachoroidal transretinal stimula‐
tion (STS), and artificial corneas among others, which are changing nowadays due to the new
advancements in technology and also due to the development of new biomaterials, new
microelectrodes, and several types of neural devices around the world. Now, real “artificial
eyes” are not only the craniofacial, maxillofacial, ocular, and orbital prostheses that replaces
an absent eye after an enucleation but they are also new materials such as cryolite glass, gel
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from cellulose, glass, silicone and porous polyethylene, graphene, dental biopolymers among
others that are being implemented as materials for the heart, eye, and other organ implants
due to their characteristics to improve good biological compatibility, be more resistant, reduce
allergies, and improve durability. These implants are used for the replacement of the orbital
content of anophthalmic cavities [2].
The traditional concept of ocular prostheses (ocular, orbital, epithesis, and maxillofacial),
visual implants (retinal, optic nerve, cortical, subretinal, epiretinal and cortical), and others of
engineering and biomedical sciences have been changing and must be reviewed in the future.
Otherwise, digital cameras, electrodes, and other electronic devices are useful for the visually
impaired. In France, there has been some work on retinal implants using nanodiamonds in the
artificial retina. This allows converting light signals into electrical signals. In the field of ocular
pharmacology, the nanocarrier molecules for the sustained release of drugs and other devices
to vitrectomies are some of the significant visual health advancements in the recent years.
Additionally, in the field of contact lenses and artificial corneas, biopolymers have been
developed for the early detection of keratoconus or systemic diseases. Nanotechnology is
emerging as a science applied to the visual industry and medicine, involving a multidiscipli‐
nary team that requires new directions in the role and performance of ocular professionals
around the world in the near future. The handling of materials and processes at the nanoscale
(one billionth of a meter) level, the instrumentality in the accurate detection, and the telere‐
habilitation intervention using robots of bioelectrical retinal implants nano lenses are just some
of the promising developments in the field of eye care. Visual health professionals seek the
entry of this science in our curricula, research, and training discipline for innovation and
technology based on nanotechnology and robotics. The high costs should not prevent the
alliance between university research centers and the private industry in bringing innovation
to our population and creating transdisciplinary research lines to improve the quality of life
in eye health.
In the recent years, we have reviewed scientific literature regarding publications in surgical
techniques of eye surgery. The number of publications on visual implants, artificial corneas,
stromal rings, and cross linking has increased in the same manner as the development of new
patents did. Also in the recent years, the inclusion of digital imaging systems, visual simulators,
and virtual and augmented reality, prior or during the surgeries, have taken place. Some of
the ophthalmic surgical procedures mentioned above are useful for improving the life quality
of patients. This may pose a challenge to ophthalmic surgeons, but, has improved the quality
of life of patients and their rehabilitation. The topics are discussed under the following areas:
pre-operative tests, operative surgery, prevention of complications and current and future
major advances in eye surgery of importance to surgeons, researchers, physicians, and health
personnel.
3. Eye surgery on literature
Global announcements regarding new developments in eye surgery across all fields require a
systemic search for there are many institutions and authors contributing to this knowledge.
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To perform this review, keywords were used: Eye surgery and refractive surgery, eye surgery
and visual implants, eye surgery and retinal implants, glaucoma eye surgery, and cataract eye
surgery. The resources used were Medline and Scopus criteria for the inclusion of surgical
techniques (1990-2014). In this review, it has been noted that many institutions have increased
ophthalmology publications in these areas and in recent years, advancements in electronic
chips to the retina and visual and retinal implants are growing considerably.
Many eye care research institutes supported by the government and universities from all
continents have been working for decades on innovations for eye surgery across all fields
(cataract, refractive surgery, stromal rings, and retinal implants), which has been progressing
in different countries as evidenced by scientific literature.
Scientific publications related to refractive surgery around the world and the institutes that
have most published reports on refractive surgery can be seen in the chart below. Scopus
analysis  can  be  useful  creating  partnerships  between  researchers  in  the  same field.  See
Figure 1 [3].
Figure 1. Publications of refractive surgery from Ophthalmology Institutes and Universities around the World from
the last decades. Copyright 2015. Elsevier B.V. All right reserved. Scopus is a registered trademark of Elsevier B.V.
Literature reviews on retinal implants, which previously seemed like science fiction, has
become a research field not only in ophthalmology and medicine, but also in electronic
engineering and nanotechnology. Therefore, these researches should not only make journals
specialize in medicine, but the revisions should also include nanotechnology and engineering
to make it more accurate. In Figure 2, reports regarding retinal implants that were made by
principal countries have been proven evident.
Institutions and universities are making major breakthroughs in the field of retinal implants
for more than two decades. In fact, some already have several patents, prototypes, and
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experimental models in animals. There is already evidence in humans, which provides a
promising future for people with retinitis pigmentosa, which a few years ago would have been
considered impossible. See Figure 3 [3].
Figure 3. Top Publications in retinal implants for institutes and Universities around the World. Copyright 2015. Elsevi‐
er B.V. All right reserved. Scopus is a registered trademark of Elsevier B.V.
Figure 2. Publications in retinal implants in different countries. Copyright 2015. Elsevier B.V. All right reserved. Sco‐
pus is a registered trademark of Elsevier B.V.
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4. Types of eye surgery
Today, the classification of eye surgery can be summarized in Figure 4.
Figure 4. Classification of the types of eye surgery.
5. Ocular surgical techniques
In the surgery of myopia, astigmatism, and presbyopia, several techniques have improved
since the 80s (See figure 5). And recently, a stromal ring technique has been introduced for
keratoconus. Due to the shortage of donors for corneas, the stem cell culture and the devel‐
opment of new biopolymers has increased until the creation of several artificial corneas.
6. Corneal surgery
The corneal transplant surgery is useful in the removal and replacement of damaged corneas,
replacing it with a clear donor cornea (corneal grafting) in its entirety (penetrating keratoplas‐
ty) or in part (lamellar keratoplasty). Another surgical technique is the deep anterior lamellar
keratoplasty (remotion of the anterior layers of the central cornea) if the replacement includes
posterior cells: endothelia, stroma and Descemets cells (DSEK) or Descemets/endothelium
(DMEK).
Boston keratoprosthesis is a synthetic cornea used since 2008 (Boston KPro), which was
developed for the Massachusetts Eye and Ear Infirmary. The AlphaCor, a device that contains
a peripheral skirt and a transparent central region, is another artificial cornea. The parts connect
interpenetrating polymer network made from poly-2-hydoxyethylmethacrylate (pHEMA).
Another model is the osteo-odonto-keratoprosthesis, wherein a lamina of the patient´s tooth
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is implanted into the eye using an artificial lens. The porous graphite/PVA hydrogel composite
as the skirt of artificial cornea, in the experimental model shows the interconnective porous
network. The mechanical properties and water content are similar to nature donor cornea.
Water content is another crucial characteristic of hydrogel used as a material for artificial
cornea because it will influence the biocompatibility of hydrogel. Experimental studies
developed in rabbits in vivo shows that the hydrogel nanocomposite implants of Zn NP were
well tolerated in over 3 weeks of study, with no evidence of wound leakage, infection,
inflammation, or neovascularization [4].
Corneal cross-linking is a technique used for the treatment of keratoconus. It increases the
corneal rigidity by photo polymerization of the stromal collagen fibers with UV light for less
than 30 minutes. The standard cross-linking technique, also called Dresden protocol (CXL),
requires the removal of the central 9 nm of the corneal epithelium layer followed by 30 minutes
of riboflavin administration [5].
In order to make a predictive value pair wing refractive surgery and have a more accurate and
useful value for refractive surgery and the stromal rings for keratoconus, sophisticated
software have been developed to help surgeons take more precise models before the surgery.
Some of them are provided by manufacturers and others have been developed based on
sophisticated mathematical models, which are very useful in cases of keratoconus or corneal
astigmatism [6].
Nomograms are incisions within the cornea without the need to break the epithelium or
Bowman´s, thus avoiding the risk of wound problems and possible overcorrections during
refractive surgery. Recently, specialized software products can help surgeons on the different
procedures. Some of them are IBRA, Intacs®, and Nomograms (useful for ICRS in keratoconus
by the use of a ring base on the type of the cone) [7, 8, 9]. In presbyopia surgery, an optical
Figure 5. Corneal surgery techniques.
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device as thin as a contact lens is inserted into the cornea to reshape the front surface of the
eye in order to improve vision. Corneal inlays are used to improve near vision and reduce the
need for reading glasses. This device can be combined with LASIK for nearsightedness,
farsightedness, and/or astigmatism.
This procedure is less invasive than phakic IOL (intraocular lenses placed deeper in the eye).
So, with the corneal inlays for vision correction, eye surgeons may sometimes be able to avoid
complications associated with procedures, such as LASIK and PRK, because no corneal tissue
is removed. The Kamra Corneal Inlay, previously called ACI 7000, for presbyopia is now in
clinical trials. The device in inserted in a thin flap in the center of the cornea. The flap is then
replaced over the inlay to hold it in place in a process of 15 minutes [10].
Its innovation holds a promise to replace reading glasses with good near vision in the near
future. The characteristics of Kamra are described as follows: 3.8 millimeters in diameter, 10
microns thick, made of an opaque biocompatible polymer (Kynar), and a thermoplastic
material that softens in heat and hardens in cooler conditions.
Corneal inlays and onlays are also called keratophakia. They are implants placed in the corneal
stroma for the correction of presbyopia. The procedure is done under topical anesthesia and
the implant is done monocularly in the non-dominant eye as a stromal pocket or under the
flaps created by the microkeratome or by the femtosecond laser. See Figure 6.
Figure 6. Position of the corneal onlay implants.
Other innovations for these techniques have been developed for researchers in Mexico, who
are working on Raindrop near Vision Inlay (ReVision Optics) with some variation on diame‐
ters, thickness, and biomaterials.
This inlay is placed in the cornea under a LASIK-style flap. When in position, the inlay changes
the curvature of the cornea so the front of the eye acts much like a multifocal contact lens. The
other alternative is the Flexivue Microlens (Presbia Cooperatief U.A., Amsterdam), which uses
a laser and creates a tiny pocket just below the eye's surface. Currently, it requires developing
the instrument to insert the microlens in the pocket that is sealed to hold the lens, and a
hydrophilic polymer is irrigated during surgery with a highly moisturizing substance. The
synthetic intraocular lens replaces the natural lens during cataract surgery. Its characteristics
are as follows: 3 mm in diameter and 20 microns thick at the edges [11].
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7. 3D Models for training and surgery
7.1. Glaucoma
Some helpful preoperative aids recently included for prior surgery are the 3D models. These
must be used to investigate the pressure drop on the localization of the main resistance to
aqueous egress during iridectomy or trabeculectomy surgery. Some of these are the modeling
of the eye drainage using the computational fluid dynamics (CFD) and the eye drainage system
devices (GDD). To provide a 3D CFD prototype of the eye, the basis is the anatomy of a real
human eye. Some models are based on stacks of microphotographs from human eye slides
from which digital processing of the images of the eye structure and 3D reconstruction of the
model are performed. The simulations of the distribution of pressure and the flow velocity in
the model of a healthy eye bring results comparable to physiology references. Mimicking
glaucoma conditions, most likely the real eye, led to an increase of the IOP from normal range,
which went down to lower values after a filtering procedure. With this, a computer assisted
design (CAD) model of the device is inserted in the 3D eye through the DC and the trabecular
meshwork of the anterior chamber angle, parallel to the plane of the iris [12].
7.2. Cataract surgery
A simulation, very similar to the real environment, has been implemented, so the training for
the surgeon is more secure. It is also in real-time as a virtual simulator with a control position
tracking in a stereoscopic display mounted on a head, with a video, audio, and haptic interface
in virtual reality. A real environment has been simulated that is created electronically in a
controlled and protected environment where the surgeon can learn, practice, and improve
their skills for surgery in a safe environment [13].
SensAble Phantom Omni T.M is equipped with a device that controls virtual surgical instru‐
ments and feeds the skills of the surgeon, allowing six degrees of freedom tracking, three of
which are important in human-machine interface for simulation. A haptic interface is designed
to identify the types of surgical operations, such as cutting, grasping, pushing, emulsion, and
calculated reaction force, and allows modeling the deformation of the mesh fabric, such as an
eye model. The cyanoacrylate polymerizes as soon as it touches something like water and
aqueous or saline solution. Fibrin glue is also another sealant that is also used for pterygium
with conjunctival auto-grafts and secures amniotic membrane tissue in pterygium surgery.
Sealants made of polyethylene glycol hydrogel are used for sealing corneal incisions and
implantation in the IOL [14].
8. 3D Bioprinting
3D printing, better known as bioprinting, has been widely accepted in the health industry. This
was initially developed to print 3D process designs in the gastronomy industry. Later on, it
has become one alternative medicine for organ replacement. Printing with organs like heart,
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liver, kidney, replacement hip bones, and maxillofacial trachea has become an alternative in
association with research on stem cells to regenerate tissue. Eye level attempts have been cast
for 3D modeling and future impressions of the eyeball for cosmetic purposes in people
requiring ocular prostheses turned what was previously artisanal towards a more precise
subsequent enucleation process. This improves the aesthetic value and lowers the probability
of infection that occurs in these tissues due to poor hygiene because there is no need to
frequently remove it for cleaning purposes [15].
This process consists of the printing, layer by layer, on a 3D printer using stable biological
materials applied in tissue engineering. Very few materials, which fulfill the requirements for
bioprinting as well as provide adequate properties for cell encapsulation during and after the
printing process, are available. Some of the materials that are similar to the contact lens
hydrogel composite or include alginate and gelatin precursors were tuned with different
concentrations of hydroxyapatite (HA) and were characterized in terms of rheology, which is
the swelling behavior and mechanical properties used to assess the versatility of the system
properties [16].
9. Development on visual implants
The LIS-CEA laboratory in France has been studying retinal implants from nanomaterials
and nanodiamonds. By means of the implementation of memristors and digital technolo‐
gy, electronic devices that respond to Moore's Law (processing speed, memory capacity,
and number of pixels) inspired the creation of cardiac pacemakers and created an intelli‐
gent flash. This concept was introduced by Leon O. Chua and was developed as a model
of neural networks, the biomimetic model of the retina, where they expected to even send
3D signals. [17].
A project was undertaken wherein other technologies using silicon microchips as a "wafer" to
create a biological and electronic device in the form of functional circuits that interact with live
cells and shows a promise for the present and future cells. The construction of the small three-
dimensional models of the human organs can be used to treat and replace costly and time-
consuming animal studies that currently hamper the development of drugs. Furthermore,
these micro-electromechanical systems (MEMS) allow testing in cell cultures without using a
full tissue. A lab-on-a-chip enables the replication of tissue samples [18].
FDA approved a project of more than 15 years which comprised an interdisciplinary group of
researchers. The retinal prosthesis was created: Second Sight Argus II, with funding from the
National Eye Institute. It consists of a camera that captures images via implanted electrodes
that stimulate cells in the retina, producing a light on the patient's visual field. This camera
mounted on a pair of eyeglasses wirelessly (with 60 electrodes and hoping to increase it to
1500), has an array of microelectrodes and is mounted on a miniature camera on a pair of
glasses that act as a sensitive photodiode light. The camcorder captures a portion of the visual
field and transmits the information to the VPU. The device is already being used in patients
with retinitis pigmentosa [19].
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Traditionally, the aesthetics of the manufacturing and fitting of ocular prostheses are accept‐
able and responds efficiently in improving the patient’s confidence and physical and psycho‐
logical well-being, therefore, helps to improve their social acceptance and quality of life.
Recently, the introduction of visual implants is a different alternative designed to transmit
electronical signals from the retina to the brain. According to the surgical technique and
position, they are inserted or transplanted into the body and tend to be used as a therapeutic
instrument for visual rehabilitation. The artificial stimulation to the visual pathway allows the
brain to recognize the electric signal as light. New electronical materials useful for the
fabrication of these devices have been developed in the recent years. An ocular prosthesis helps
the patient psychologically and improves confidence, but doesn’t have a visual function.
Different techniques are available to fabricate a custom ocular prosthesis. In contrast, visual
implants are currently being developed as an innovation to restore nerve impulses between
the eyeball and the cerebral cortex, linking transdisciplinary efforts, electronic engineers, and
ophthalmologists worldwide working to develop the bionic eye. The researchers are focused
to allow and improve the perception of spots of light and high contrast edges by means of the
devices´ stimulator as electrodes or optogenetics transducers.
See Figure 6 [20].
Figure 7. Classification of Ocular implants. Durán, P. Diaz, M, Plaza, J. Journal of ocular diseases and therapeutics. 2
N. 1, 2014.
Ocular prostheses were made and are still fabricated in inhert and non-integrable materials,
such as polymethylmetacrylate (PMMA) and cryolite glass. But these days, integrable
materials for anophthalmic cavities, such as a gel from cellulose produced by Zoogloea sp.
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porous polyethylene dental biomaterial composites and graphene among others, are imple‐
mented as materials for the heart, eye and other organs implants due to their characteristics
in improving biological compatibility to be more resistant, to reduce allergies, and improve
durability. The future development of the ocular prostheses is focused on the impression of
digital measurements, 3D modeling software, and the digital impression of the iris [21].
Many implants are being studied around the world. Some patents and other humans have
been implanted to help in visual rehabilitation. Some of these examples are divided into two
categories according to design or operations principles, some use an external camera and image
processing drive implanted electrodes. Another example is the use of 1500 small units in
microphotodiode arrays (MPA by Retina Implant AG) and Stanford retinal prosthesis. Some
required external energy to drive the stimulators, while others are wireless. The Stanford array
projects a high intensity infrared image on the implanted photocells and generates a sufficient
current to excite the secondary neurons. In addition, the classification must be made according
to the implant site e.g., in the inner retinal (epiretinal) or outer (subretinal) retinal surface; if
the implant is inserted below the choroid plexus (suprachoroidal) or if the implantation take
place outside the sclera (episcleral) [22, 23, 24].
Before the production of visual implants, many studies should be performed to verify the noise
pattern, the extraction processing of the temporal space, monitoring to check the quality of the
image, the spatial resolution, the circuit architecture, and advanced intelligent functions.
The future smart 3D image sensor architectures will most probably consist of a sensor layer at
the top and various processing layers below. Each layer will be organized into locally con‐
nected cellular arrays with additional global communication/operation mechanisms. Layers
will be vertically interconnected using bi-directional parallel channels implemented by
through-silicon-vias (TSVs). Images at different scales and abstract information about salient
points and features will be transmitted top-down across the stack, while commands will be
transmitted bottom-up to support adaptation.
10. Optical Coherence Tomography (OCT) in surgery
The OCT has revolutionized the clinical management of ophthalmic diseases and promises to
be of great help in the surgical rooms. The Prospective Intraoperative and Perioperative
Ophthalmic Imaging with Optical Coherence Tomography (PIONEER), a single site multi-
surgeon prospective is incorporating the OCT to the surgical room because of feasibility, safety,
and utility. This study is performed by the Cleveland Clinic. The variables including past
ocular history, procedure type, preoperative diagnosis, techniques, and number of imaging
sessions are recorded one day before surgery. The structured study follow-up is done after the
surgery [25].
The protocol managing for them is next. Disease-specific or procedure-specific imaging
protocols (eg. scan type, pattern, density, size, orientation) were outlined for anterior and
posterior segment applications. Anterior segment imaging included a 12mm3, 12mm volu‐
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metric cube scan at 0 degree orientation. Posterior segment imaging included a 10 mm3, 10 mm
volumetric cube with 100 B-scans per volume at both 0 and 90 degrees, a 5 - 3 10mm volumetric
cube with 7 B-scans per frame for averaging, a total of 175 B-scans per volume at both 0 and
90 degrees, and a 10 mm radial scan with 100 B-scans per volume. The surgeons were provided
with guidance for surgical milestones to consider for imaging (e.g., pre-incision, following
membrane peeling, following graft placement), but the specific imaging sessions were at the
surgeon’s discretion. When possible in vitreoretinal cases, scan sequences were obtained in
the operating room prior to any surgical manipulation of the area of interest. Following various
surgical milestones, scan sequences were performed to allow for comparative data and change
analysis. A ‘‘scan’’ was defined as a single set of images. A ‘‘scan session’’ was defined as a
series of scans obtained during a single pause during surgery. Typically, multiple scan sessions
were often performed during the surgical procedures. A specific surgical procedure (e.g.,
Membrane peeling, lamellar keratoplasty) intraoperative OCT feedback form was included as
part of the study protocol. This form included questions regarding the impact of the intrao‐
perative OCT on surgical decision making and on how intraoperative OCT may have impacted
the understanding of the surgical disease of interest. OCT provides rapid testing that reduces
costs, time, and enhances quality care for surgeons and patients [26].
11. Further research
Future research of new innovations in visual implants improves existing research for best
results. The early implementation of refractive surgery and cataract surgery is recalled,
however, it is important that the increase of that research is conducted in global scientific
communities where you can monitor patients and have access to people with visual impair‐
ment that requires the surgery. High costs should be borne by health systems, according to the
laws of each country, so that they can be taken advantage by the patients who need them. Some
of the challenges that are presented in eye health are the cost of the technology transfer, more
high-level training in surgical procedures, and the establishment of protocols according to the
clinical findings. Just as eye surgery has been the pioneer in the world among many techno‐
logical advancements, it becomes a possible reality in the near future to restore vision for visual
rehabilitation and to provide a better quality of life for visually impaired patients.
Likewise, due to the interaction of the new sciences, ophthalmologists around the world should
have comprehensive training from his clinical practice in various branches of medicine,
biomedical engineering and electronics, and nanotechnology. Team groups with different
point of views must be formed to answer the needs of patients, such as applying science to the
clinic, establishing protocols to prevent errors, and improve processes in eye surgery and thus,
optimizing costs, human resources and effectiveness for patients. All these innovations must
be reimbursed by health insurance systems around the world.
So that these advancements reach patients, there should be access to global insurance to cover
the population that needs them. Germany and the United States are already doing this.
However, in underdeveloped countries, this possibility does not even exist and is yet to be
built.
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The truth is that in the near future, these new surgeries may have results that help reduce
blindness, improve the coverage and quality of life for patients with myopia, astigmatism,
presbyopia, cataracts, and retinitis pigmentosa among others. The inclusion of contact lenses
has always been considered as one of the most important innovations for mankind. But this
technology is linked to new projects and has developed new biopolymers. The challenge for
innovators and surgeons in the next decades is the immersion with electronic chips. The
accuracy of current studies is required and must be taken advantage by the academic com‐
munity for the scientific needs and reading of the general population.
Another important area in future work on education to transfer this technology and provide
updates with experts and developers for the patients’ safety, must be worked in partnership
with the different industries and academia.
12. Conclusion
Eye surgery is not only considered a pioneer in the world by technological advancements, but
evidence also shows that it has been and will continue to be important to combat blindness in
the world. Among the most significant advancements are visual implants, artificial corneas,
new biopolymers, and the inclusion of nanotechnology in operating rooms where other major
global challenges will come from.
The challenge of new visual innovation includes multiple fields that must continue to be
improved for these new global developments in refractive surgery, ocular prosthesis, and
visual implants. In order to make these advancements accessible to patients, it is required to
improve the transfer of technology and improve the training of surgeons around the world.
The following points must also be taken into consideration:
1. Eye surgery research: strengthening global researchers’ mobility and internships among
researchers of visual health-electronical engineering groups around the world to be
training in transdisciplinary teams about the new surgical technique and developments
in electronic engineering and their applications to visual health. It must include develop‐
ments for other healthcare artifacts.
2. Financial resources: search financial resources from government and public and private
entities to develop new technology transfer policies.
3. Database creation for target population in visual implants or visual rehabilitation: the
creation of a global database of possible patients that can benefit from these innovations
should be a priority in each country and will make us plan for monitoring, check the
progress in new implanted patients, verify the recovery rates, and design a project of the
improvement thereof.
4. Challenge for Institutional Review Boards (IRB committees) of academic institutions: The
Institutional Review
5. Boards of universities around the world should construct and share global protocols about
new technology surgery: to take care of the visual implants, fill up the informed consent
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in the use of these new innovations, provide mechanisms for timely and appropriate
communication to users, investors, and inventors, and report the cost - benefits of these
new alternatives.
6. Marketing: The other challenge is the distribution channels. A highly qualified medical
and rehabilitation staff is required after the implantation: a team of psychological support,
visual rehabilitators, and low vision experts around the world. Most importantly, family
support is key for a successful visual recovery. In the case of ocular prosthesis, the personal
cleaning regime requires periodic professional care. Some authors have proposed the
three phase model according to the discharge associated with prosthetic eye wear. In the
initial period, the freshly polished prosthesis set the homeostasis in the first phase as
surface deposits are removed is more comfortable and safer. However, you can make an
increased likelihood of harm when continued wear, that´s is the reason to think in recovers
such as nanofilms or new biopolymer can reduce the deposits another way is the tradi‐
tional surface polish. There is not too much published literature about maintenance care
of visual prosthesis, electrodes and microarrays.
The new research for eye surgery is focused on the development of artificial organs, ocular
prosthesis, and the inclusion of new biomaterials as graphene or nanocoatings against biofilm
and microorganisms. This creates digitalized prototypes and is customized for each patient,
using new technology and working with 3D printing organs. Some advancements have been
developed in the United Kingdom, in partnership with Fripp Design and Research and
Manchester Metropolitan University, using the Spectrum Z-Corp 510 3D printer. The main
reason for inclusion of graphene as an ocular biomaterial is because this material serves as a
photovoltaic semiconductor, which is unlike the metal or silicon-based materials used until
now for such biotechnological interfaces. The graphene is soft, light, flexible and highly
biocompatible. Naturally, new biomaterials and neuro-implants is the challenge for visual care
for sensitivity to visible light. It uses photovoltaic material and does not require an external
electrical source to function.
Nomenclature
AK: Astigmatic Keratoplasty
ALK: Automated lamellar keratomileusis
BANG: Bits, Atoms, Neurons, and Genes.
CK: Conductive keratoplasty
GNR: Genetics, Nanotechnology and Robotics.
GRIN: Genetic, Robotic, Information, and Nanotechnology.
ICR: Intracorneal rings.
LRI: Limbal relaxing keratoplasty
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LTK: Laser termal keratoplasty
NBIC: Nanotechnology, Biotechnology, Information technology and Cognitive science.
OOKP: Osteo-Odonto-Keratoprosthesis
LASEK: Lasser assisted subepithelial keratomileusis
OCT: Optical Coherence Tomography
PIONEER: Prospective Intraoperative and Perioperative Ophthalmic Imaging With Optical
Coherence Tomography
SEB: scleral expansion bands
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